✦ LIBER ✦

Interpretation of positive patient response to efalizumab for the treatment of moderate to severe plaque psoriasis

✍ Scribed by Stephen Stone; Kim Papp; Ivor Caro; Brian Bresnahan

Book ID: 116579004
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 59 KB
Volume: 50
Category: Article
ISSN: 1097-6787
DOI: 10.1016/j.jaad.2003.10.551

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efalizumab effective for moderate-to-sev

Efalizumab effective for moderate-to-severe chronic plaque psoriasis

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Efalizumab: long-term efficacy in modera

Efalizumab: long-term efficacy in moderate-to-severe plaque psoriasis

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Safety and efficacy of efalizumab therap

Safety and efficacy of efalizumab therapy for elderly patients with moderate to severe chronic plaque psoriasis

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

The safety of efalizumab in patients wit

The safety of efalizumab in patients with moderate to severe plaque psoriasis: summary of clinical trial experience

✍ Craig Leonardi; Bernard Goffe; Jeff Sobell; Ivor Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Safety of Efalizumab Therapy in Patients

Safety of Efalizumab Therapy in Patients with Moderate to Severe Psoriasis

✍ Dr Tiffani Hamilton, Alan Menter, Ivor Caro, Peter Compton, Jeffrey Sobell, Kim 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 123 KB

Ustekinumab useful for moderate-to-sever

Ustekinumab useful for moderate-to-severe plaque psoriasis

📂 Article 📅 2008 🏛 Adis International Limited (now part of Wolters Kl ⚖ 195 KB